ZA782209B - Pyridazinone derivatives - Google Patents

Pyridazinone derivatives

Info

Publication number
ZA782209B
ZA782209B ZA00782209A ZA782209A ZA782209B ZA 782209 B ZA782209 B ZA 782209B ZA 00782209 A ZA00782209 A ZA 00782209A ZA 782209 A ZA782209 A ZA 782209A ZA 782209 B ZA782209 B ZA 782209B
Authority
ZA
South Africa
Prior art keywords
pyridazinone derivatives
pyridazinone
derivatives
Prior art date
Application number
ZA00782209A
Other languages
English (en)
Inventor
G Thuillier
S Mignonac
Original Assignee
Rolland Sa A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolland Sa A filed Critical Rolland Sa A
Publication of ZA782209B publication Critical patent/ZA782209B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C07D237/16—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA00782209A 1977-04-28 1978-04-18 Pyridazinone derivatives ZA782209B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7712888A FR2388799A1 (fr) 1977-04-28 1977-04-28 Derives de pyridazinone, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
ZA782209B true ZA782209B (en) 1979-04-25

Family

ID=9190051

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00782209A ZA782209B (en) 1977-04-28 1978-04-18 Pyridazinone derivatives

Country Status (18)

Country Link
US (1) US4188388A (fr)
JP (1) JPS53135993A (fr)
AU (1) AU3552678A (fr)
BE (1) BE866492A (fr)
DD (1) DD135488A5 (fr)
DE (1) DE2817649A1 (fr)
ES (2) ES469234A1 (fr)
FR (1) FR2388799A1 (fr)
GB (1) GB1584119A (fr)
IE (1) IE46730B1 (fr)
IL (1) IL54547A0 (fr)
IT (1) IT1111174B (fr)
LU (1) LU79520A1 (fr)
NL (1) NL7804374A (fr)
NZ (1) NZ187085A (fr)
PL (1) PL112610B1 (fr)
PT (1) PT67958B (fr)
ZA (1) ZA782209B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
CA2450073C (fr) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions et procedes de modulation du transport a travers la barriere hematho-encephalique
EP2671508B1 (fr) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Système pharma-informatique
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
US8076334B2 (en) * 2007-09-20 2011-12-13 Hoffmann-La Roche Inc. Prodrugs of thyroid hormone analogs
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
PL227639B1 (pl) 2014-05-28 2018-01-31 Werner Kenkel Spolka Z Ograniczona Odpowiedzialnoscia Platforma ekspozycyjna

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1913265A1 (de) * 1969-03-15 1970-10-01 Basf Ag Verfahren zur Herstellung von 2-Alkylpyridazoniumverbindungen

Also Published As

Publication number Publication date
IT1111174B (it) 1986-01-13
BE866492A (fr) 1978-10-27
PT67958A (fr) 1978-05-01
US4188388A (en) 1980-02-12
AU3552678A (en) 1979-11-01
IL54547A0 (en) 1978-07-31
ES469234A1 (es) 1980-05-16
LU79520A1 (fr) 1978-11-28
NZ187085A (en) 1979-12-11
JPS53135993A (en) 1978-11-28
PL206456A1 (pl) 1979-04-23
PL112610B1 (en) 1980-10-31
PT67958B (fr) 1979-11-14
IE780778L (en) 1978-10-28
NL7804374A (nl) 1978-10-31
ES476449A1 (es) 1979-05-16
IT7822754A0 (it) 1978-04-27
FR2388799A1 (fr) 1978-11-24
DD135488A5 (de) 1979-05-09
FR2388799B1 (fr) 1980-06-27
DE2817649A1 (de) 1978-11-09
GB1584119A (en) 1981-02-04
IE46730B1 (en) 1983-09-07

Similar Documents

Publication Publication Date Title
IL55387A0 (en) Triphenylalkene derivatives
AU4113878A (en) 1-alkanoyl-proline derivatives
GB2003876B (en) Beta-haloethylamine derivatives
PH12853A (en) Meta-sulfonamido-benzamide derivatives
GB2008579B (en) 2-imino-imidazolidine derivatives
AU3888578A (en) 4-hydroxy-2-benzimidazolinone derivatives
AU3552678A (en) Pyridazinone derivatives
GB2009180B (en) 25-alkylcholestrerol derivatives
GB2009150B (en) Tetrahydrophtalamide derivatives
PH14637A (en) Oxadiazolopyrimidine derivatives
HK28784A (en) Prostanol derivatives
GB2005261B (en) 2-oxazolydone derivatives
PH13915A (en) Chinazoline derivatives
EG13411A (en) Herbicidal-haloacetamides
IL56042A0 (en) Prostanglandin derivatives
NZ188863A (en) 2-oxo-hexahydroazepine -piperidine and -pyrrolidine derivatives
GB2014131B (en) 1-hydrocarbylpyrrole derivatives
GB2003479B (en) 3-amino-17alpha-aza-d-homoandrostane derivatives
AU3313978A (en) Everninomicin derivatives
GB2000128B (en) 15-substituted-omega-pentanorprostaglandin derivatives
GB2000769B (en) 4 - homoisotwistane derivatives
GB2008119B (en) Arylsteroid derivatives
AU4129978A (en) Eburnamenine derivatives
GB2060630B (en) Pyrazinoquinoline derivatives
GB2002776B (en) Peruvoside derivatives